CAPSTONE GREEN ENERGY CORP (CGRN)

US14067D5086 - Common Stock

0.37  +0.06 (+19.35%)

After market: 0.3011 -0.07 (-18.62%)

Fundamental Rating

1

Taking everything into account, CGRN scores 1 out of 10 in our fundamental rating. CGRN was compared to 86 industry peers in the Electrical Equipment industry. CGRN has a bad profitability rating. Also its financial health evaluation is rather negative. CGRN is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year CGRN has reported negative net income.
In the past year CGRN has reported a negative cash flow from operations.
In the past 5 years CGRN always reported negative net income.
CGRN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

CGRN's Return On Assets of -18.29% is on the low side compared to the rest of the industry. CGRN is outperformed by 61.36% of its industry peers.
With a Return On Equity value of -1757.75%, CGRN is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -18.29%
ROE -1757.75%
ROIC N/A
ROA(3y)-22.38%
ROA(5y)-21.03%
ROE(3y)-227.41%
ROE(5y)-158.59%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CGRN's Gross Margin of 14.06% is in line compared to the rest of the industry. CGRN outperforms 40.91% of its industry peers.
In the last couple of years the Gross Margin of CGRN has grown nicely.
The Profit Margin and Operating Margin are not available for CGRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y39.37%

0

2. Health

2.1 Basic Checks

CGRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CGRN has been increased compared to 1 year ago.
CGRN has more shares outstanding than it did 5 years ago.
CGRN has a worse debt/assets ratio than last year.

2.2 Solvency

CGRN has an Altman-Z score of -12.69. This is a bad value and indicates that CGRN is not financially healthy and even has some risk of bankruptcy.
CGRN has a worse Altman-Z score (-12.69) than 94.32% of its industry peers.
CGRN has a Debt/Equity ratio of 49.90. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 49.90, CGRN is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 49.9
Debt/FCF N/A
Altman-Z -12.69
ROIC/WACCN/A
WACC8.69%

2.3 Liquidity

A Current Ratio of 0.70 indicates that CGRN may have some problems paying its short term obligations.
CGRN has a worse Current ratio (0.70) than 92.05% of its industry peers.
CGRN has a Quick Ratio of 0.70. This is a bad value and indicates that CGRN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CGRN (0.42) is worse than 92.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.42

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.58% over the past year.
The Revenue has been growing slightly by 4.24% in the past year.
CGRN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.04% yearly.
EPS 1Y (TTM)5.58%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q17.65%
Revenue 1Y (TTM)4.24%
Revenue growth 3Y-5.83%
Revenue growth 5Y-2.04%
Revenue growth Q2Q-4.87%

3.2 Future

The Earnings Per Share is expected to grow by 25.33% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.71% on average over the next years. This is a very strong growth
EPS Next Y18.64%
EPS Next 2Y34.55%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue Next Year4.45%
Revenue Next 2Y7.35%
Revenue Next 3Y6.56%
Revenue Next 5Y27.71%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

CGRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CGRN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CGRN's earnings are expected to grow with 25.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.55%
EPS Next 3Y25.33%

0

5. Dividend

5.1 Amount

CGRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAPSTONE GREEN ENERGY CORP

NASDAQ:CGRN (10/4/2023, 7:00:00 PM)

After market: 0.3011 -0.07 (-18.62%)

0.37

+0.06 (+19.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.79M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.29%
ROE -1757.75%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 14.06%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 49.9
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.7
Quick Ratio 0.42
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)5.58%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y18.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.24%
Revenue growth 3Y-5.83%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y